SOHLIYA, A. E. L. Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation. International Journal of Research in Medical Sciences, [S. l.], v. 13, n. 2, p. 987–988, 2025. DOI: 10.18203/2320-6012.ijrms20250291. Disponível em: https://www.msjonline.org/index.php/ijrms/article/view/14638. Acesso em: 30 sep. 2025.